医学硕士毕业论文参考文献案例的详细论述

　　论文是每个毕业生都头痛的一大难题，医学硕士毕业论文就更是难上加难，不仅要有够强的医学理论功底，还要结合医学实践进行撰写。今天就给大家介绍介绍医学硕士毕业论文的参考文献该如何写，并对其进行详细介绍。希望可以帮到即将毕业的医学硕士毕业生。

　　参考文献一：

　　[1]顾招兵，李明丽，兰国湘等.哺乳仔猪的死亡原闪分析[J].中国倉牧志，2013,49(16):65-67.

　　[2]张明海,张虹虹.母猪产后缺乳症的防治办法[J].今日养猪业，2012，(1):22-24.

　　[3]毛成荣.辩i正施治母猪产后缺乳[J].山东畜牧兽医，2011,(1):69-70.

　　[4]彭金霞.产后缺乳症的综合防治[J].黑龙江备牧兽医,2010,(16):65.

　　[5]李春云，范奍元,李养霞.母猪缺乳症的防治[J].养殖技术顾问，2008，(3):61

　　[6]宋敏，走晨,陈婉文等.催奶灵注射液对溴隐亭诱发大鼠缺乳的治疗作W[J].华南农业人学学报,2011,32(2):119-121.

　　[7]庄桂玉.母猪产后缺乳的原因与防控[J].农村养姐技术，2013,(9):17-19.

　　[8]夏道伦.母猪产后泌乳障碍综合征的发病原因及其应对抬施[J].广东词料，2014,(3):43-46.

　　[9]彭代,张洪培，何贵芳等.规模化养猪场母仔猪屮药保健程序[J].屮f1?医学杂志,2008，(1):1-2.

　　[10]郭春燕，杨继生.母猪产后无乳能的预防与治疗[j].农业技术与装备，2014，(14):74-75，78.

　　[11]AndrewsZB,GrattanDR.TheRolesofDopamineandtheNeurointermediateLobeofthePituitaryintheRegulationofProlactinSecretionDuringLatePregnancyinRats[J]JournalofNeuroendocrinology,2004,16(10):859-865.

　　[12]HoytRF,TashjianAH.Immuno-cytochemicalAnalysisofProlactinProductionByMonolayer-culturesofGh3RatAnterior-pituitaryTumor-cells.1.Long-termEffectsofStimulationwithThyrotropin-releasing-hormone(trh)[J].AnatomicalRecord,1980,197(2):0-153.

　　[13]HealyDL.EndometrialProlactinandImplantation[J].BaillieresClinicalObstetricsandGynaecology,1991,5(1):95-105.

　　[14]MircheffAK,WarrenDW,WoodRL,etal.ProlactinLocalization,Binding,andEffectsonPeroxidaseReleaseinRatExorbitalLacrimalGland[J].InvestigativeOphthalmology&VisualScience,1992,33(3):641-650.

　　[15]CurlewisJD.SeasonalProlactinSecretionandItsRoleinSeasonalReproductionaReview[J]_ReproductionFertilityandDevelopment,1992,4(1):1-23.

　　[16]LohrkeB,KunkeIS,KowitzJ,etal.ProlactinHeterogeneity-aLimitationontheEvaluationofResultsFromProlactinAssaysDuetoDifferencesinImmunoassaysandtheDifferentBioactivitiesofProlactinForms[J].EuropeanJournalofClinicalChemistryandClinicalBiochemistry,1993,31(12):815-827.

　　[17]RoysterIVl,DriscollP,KellyPA,etal.TheProlactinReceptorintheFetal-rat-Cellular-localizationofMessenger-ribonucleic-acid,ImmunoreactiveProtein,andLigand-bindingActivityandInductionofExpressioninLate-gestation[J].Endocrinology,1995，136(9);3892-3900.

　　[18]LotinunS，LimlomwongseL,KrishnamraN.TheStudyofaPhysiologicalSignificanceofProlactinintheRegulationofCalciumMetabolismDuringPregnancyandLactationinRats[J].CanadianJournalofPhysiologyandPharmacology,1998,76(2):218-228.

　　[19]BhatavdekarJM,PatelDD,ChikhlikarPR,etal.EctopicProductionofProlactinByColorectalAdenocarcinoma[J].DiseasesoftheColon&Rectum,2001,44(1):119-127.

　　[20]BulutSD，BulutS,TuzerV，etal.TheEffectsofProlactin-raisingandProlactin-sparingAntipsychoticsonProlactinLevelsandBoneMineralDensityinSchizophrenicPatients[J].NoropsikiyatriArsivi-archivesofNeuropsychiatry,2014,51(3):205-210.

　　[21]陈丼华.中两医综合干预产后缺乳理论临床研究[D].中国中科学院，2009.

　　[22]FarmerC.TheRoleofProlactinforMammogenesisandGalactopoiesisinSwine[J].LivestockProductionScience,2001,70(1):105-113.

　　[23]DalrympleA,EderyM,JabbourHN.SequenceandFunctionalCharacterisationoftheMarmosetMonkey(callithrixJacchus)ProlactinReceptor:ComparativeHomologywiththeHumanLong-formProlactinReceptor[J].MolecularandCellularEndocrinology,2000,167(1):89-97.

　　[24]BriskenC,KaurS,ChavarriaTE,etal.ProlactinControlsMammaryGlandDevelopmentViaDirectandIndirectMechanisms[J].DevelopmentalBiology,1999,210(1):96-106.

　　[25]CoyaR,AlvarezCV,PerezF,etal.EffectsofTgf-beta1onProlactinSynthesisandSecretion:anIn-vitroStudy[J].JournalofNeuroendocrinology,1999，11(5);351-360.

　　[26]BuserAC,Gass-handelEK,WyszomierskiSL,etal.ProgesteroneReceptorRepressionofProlactin/signaiTransducerandActivatorofTranscription5-mediatedTranscriptionoftheBeta-caseinGeneinMammaryEpithelialCelIs[J].MolecularEndocrinology,2007,21(1):106-125.

　　[27]Asai-satoM，NagashimaY,MiyagiE,etal.ProlactinInhibitsApoptosisofOvarianCarcinomaCellsInducedBySerumStarvationOrCisplatinTreatment[J].InternationalJournalofCancer,2005,115(4):539-544.

　　[28]BertucciPY,QuaglinoA,PozziAG,etal.Glucocorticoid-inducedImpairmentofMammaryGlandInvolutionIsAssociatedwithStat5andStat3SignalingModulation[J].Endocrinology,2010,151(12):5730-5740.

　　[29]薛琪.应用维生素E催乳的疗效观察[J].告林民学，2007，28(3):370.

　　[30]黄美凌，梁癒霞,刘笑霞等.催产素滴鼻后泌乳量及乳汁成份的观察和分析[J].护理杂志，2000,35(7):12-14.

　　[31]周生芬，李全德.泰必利治疗产后缺乳33例[J].导报，1997,(4):165.

　　[32]黄正文,孙蓉,王兰.U服多潘立酮片促进乳汁分泌[J].青岛医药卫生,2002，(2):46-47.

　　[33]朱艳华,陈冬，李淑珍等.绩毛膜促愧腺激素对过早配种黄牛产后缺乳的临床效果[J].黑龙江动物繁殖，2004,(4):16.

　　[34]王成,陈书芳.中兽医.治疗仔猪拉稀和母猪少奶[J].中国动物保健,2012，(8):48-51.

　　[35]李海江.加味催乳饮治疗母猪产后缺乳症[J].中兽医学杂志，2009,(5):24.

　　[36]曹远东,敖淸根，周志等.八珍颗粒对母猪产前产后疾病的临床应用[J].中兽医学杂志，2014，(4);50.

　　[37]花丽苑.中々：药在治疗母猪产后疾病的应用[J]./(i殖技术顾问，2010,(7):113-114.

　　[38]赵禅娟.生化汤加减在母猪产/5疾病中的临床应厅l[J].黑龙江畜牧兽民，2014,(14):104-105.

　　[39]张玉杰，.母猪催乳六法[J].中国畜禽种业,2007,(12):64.

　　[40]Bole-feysotC,GoffinV，EderyM,etal.Prolactin(prl)andItsReceptor:Actions,SignalTransductionPathwaysandPhenotypesObservedinPrlReceptorKnockoutMice[J].EndocrineReviews,1998,19(3):225-268.

　　参考文献二：

　　[1]ZUANY-AMORIMC,HASTEWELLJ,WALKERC.Toll-likereceptorsaspotentialtherapeutictargetsformultiplediseases[J].NatRevDrugDiscov,2002,1(10):797-807.

　　[2]KAWAIT,AKIRAS.TherolesofTLRs,RLRsandNLRsinpathogenrecognition[J].Internationalimmunology,2009,21(4):317-37.

　　[3]CULLENTW,GILESDK,WOLFLN,etal.Helicobacterpyloriversusthehost:remodelingofthebacterialoutermembraneisrequiredforsurvivalinthegastricmucosa[J].PLoSpathogens,2011,7(12):e1002454.

　　[4]JINMS,KIMSE,HEOJY,etal.CrystalstructureoftheTLR1-TLR2heterodimerinducedbybindingofatri-acylatedlipopeptide[J].Cell,2007,130(6):1071-82.

　　[5]KANGJY,NANX,JINMS,etal.RecognitionoflipopeptidepatternsbyToll-likereceptor2-Toll-likereceptor6heterodimer[J].Immunity,2009,31(6):873-84.

　　[6]TRIANTAFILOUM,GAMPERFG,LEPPERPM,etal.Lipopolysaccharidesfromatherosclerosis-associatedbacteriaantagonizeTLR4,induceformationofTLR2/1/CD36complexesinlipidraftsandtriggerTLR2-inducedinflammatoryresponsesinhumanvascularendothelialcells[J].Cellularmicrobiology,2007,9(8):2030-9.

　　[7]HAYASHIF,SMITHKD,OZINSKYA,etal.TheinnateimmuneresponsetobacterialflagellinismediatedbyToll-likereceptor5[J].Nature,2001,410(6832):1099-103.

　　[8]LUNDJ,SATOA,AKIRAS,etal.Toll-likereceptor9-mediatedrecognitionofHerpessimplexvirus-2byplasmacytoiddendriticcells[J].TheJournalofexperimentalmedicine,2003,198(3):513-20.

　　[9]DIEBOLDSS,KAISHOT,HEMMIH,etal.InnateantiviralresponsesbymeansofTLR7-mediatedrecognitionofsingle-strandedRNA[J].Science,2004,303(5663):1529-31.

　　[10]VANBERGENHENEGOUWENJ,PLANTINGATS,JOOSTENLA,etal.TLR2&Co:acriticalanalysisofthecomplexinteractionsbetweenTLR2andcoreceptors[J].JLeukocBiol,2013,94(5):885-902.

　　[11]MEDVEDEVAE.Toll-likereceptorpolymorphisms,inflammatoryandinfectiousdiseases,allergies,andcancer[J].Journalofinterferon&cytokineresearch:theofficialjournaloftheInternationalSocietyforInterferonandCytokineResearch,2013,33(9):467-84.

　　[12]LIJ,WANGX,ZHANGF,etal.Toll-likereceptorsastherapeutictargetsforautoimmuneconnectivetissuediseases[J].Pharmacology&therapeutics,2013,138(3):441-51.

　　[13]VAZJ,AKBARSHAHIH,ANDERSSONR.Controversialroleoftoll-likereceptorsinacutepancreatitis[J].Worldjournalofgastroenterology:WJG,2013,19(5):616-30.

　　[14]HACKAMDJ,GOODM,SODHICP.Mechanismsofgutbarrierfailureinthepathogenesisofnecrotizingenterocolitis:Toll-likereceptorsthrowtheswitch[J].Seminarsinpediatricsurgery,2013,22(2):76-82.

　　[15]FALCK-HANSENM,KASSITERIDIC,MONACOC.Toll-likereceptorsinatherosclerosis[J].Internationaljournalofmolecularsciences,2013,14(7):14008-23.

　　[16]ROHYS,SEKIE.Toll-likereceptorsinalcoholicliverdisease,non-alcoholicsteatohepatitisandcarcinogenesis[J].JGastroenterolHepatol,2013,28Suppl1(38-42.

　　[17]PRADAPO,COELHOMS,ZECCHINHG,etal.Lowsaltintakemodulatesinsulinsignaling,JNKactivityandIRS-1ser307phosphorylationinrattissues[J].TheJournalofendocrinology,2005,185(3):429-37.

　　[18]NIEDZIELSKAI,NIEDZIELSKIZ,TKACZM,etal.Toll-likereceptorsandthetendencyofnormalmucousmembranetotransformtopolyporcolorectalcancer[J].Journalofphysiologyandpharmacology:anofficialjournalofthePolishPhysiologicalSociety,2009,60Suppl1(65-71.

　　[19]BELMONTL,RABBEN,ANTOINEM,etal.ExpressionofTLR9intumor-infiltratingmononuclearcellsenhancesangiogenesisandisassociatedwithaworsesurvivalinlungcancer[J].InternationaljournalofcancerJournalinternationalducancer,2014,134(4):765-77.

　　[20]PODDAG,NYIRENDAM,CROOKSJ,etal.InnateimmuneresponsesintheCNS:roleoftoll-likereceptors,mechanisms,andtherapeuticopportunitiesinmultiplesclerosis[J].Journalofneuroimmunepharmacology:theofficialjournaloftheSocietyonNeuroImmunePharmacology,2013,8(4):791-806.

　　[21]BURDELYALG,BRACKETTCM,KOJOUHAROVB,etal.CentralroleofliverinanticancerandradioprotectiveactivitiesofToll-likereceptor5agonist[J].ProceedingsoftheNationalAcademyofSciencesoftheUnitedStatesofAmerica,2013,110(20):E1857-66.

　　[22]LUCASK,MAESM.RoleoftheTollLikereceptor(TLR)radicalcycleinchronicinflammation:possibletreatmentstargetingtheTLR4pathway[J].Molecularneurobiology,2013,48(1):190-204.

　　[23]RAJPUTS,VOLK-DRAPERLD,RANS.TLR4IsaNovelDeterminantoftheResponsetoPaclitaxelinBreastCancer[J].Molecularcancertherapeutics,2013,12(8):1676-87.

　　[24]LINYT,VERMAA,HODGKINSONCP.Toll-LikeReceptorsandHumanDisease:LessonsfromSingleNucleotidePolymorphisms[J].CurrGenomics,2012,13(8):633-45.

　　[25]SOMMARIVAM,DECECCOL,DECESAREM,etal.TLR9AgonistsOppositelyModulateDNARepairGenesinTumorversusImmuneCellsandEnhanceChemotherapyEffects[J].CancerRes,2011,71(20):6382-90.

　　[26]KAWAIT,AKIRAS.Toll-likereceptorsandtheircrosstalkwithotherinnatereceptorsininfectionandimmunity[J].Immunity,2011,34(5):637-50.

　　[27]MIYAKEK.InnaterecognitionoflipopolysaccharidebyCD14andtoll-likereceptor4-MD-2:uniquerolesforMD-2[J].Internationalimmunopharmacology,2003,3(1):119-28.

　　[28]CULINAS,BOITARDC,MALLONER.Antigen-basedimmunetherapeutics72fortype1diabetes:magicbulletsorordinaryblanks?[J].Clinical&developmentalimmunology,2011,2011(286248.

　　[29]LEHUENA,DIANAJ,ZACCONEP,etal.Immunecellcrosstalkintype1diabetes[J].NatRevImmunol,2010,10(7):501-13.

　　[30]PATTERSONCC,DAHLQUISTGG,GYURUSE,etal.Incidencetrendsforchildhoodtype1diabetesinEuropeduring1989-2003andpredictednewcases2005-20:amulticentreprospectiveregistrationstudy[J].Lancet,2009,373(9680):2027-33.

　　[31]BACHJF,CHATENOUDL.Thehygienehypothesis:anexplanationfortheincreasedfrequencyofinsulin-dependentdiabetes[J].ColdSpringHarborperspectivesinmedicine,2012,2(2):a007799.

　　[32]BLUESTONEJA,HEROLDK,EISENBARTHG.Genetics,pathogenesisandclinicalinterventionsintype1diabetes[J].Nature,2010,464(7293):1293-300.

　　[33]LIM,SONGL,GAOX,etal.Toll-likereceptor4onisletbetacellssensesexpressionchangesinhigh-mobilitygroupbox1andcontributestotheinitiationoftype1diabetes[J].Experimental&molecularmedicine,2012,44(4):260-7.

　　[34]DEVARAJS,TOBIASP,JIALALI.Knockoutoftoll-likereceptor-4attenuatesthepro-inflammatorystateofdiabetes[J].Cytokine,2011,55(3):441-5.

　　[35]DEVARAJS,DASUMR,PARKSH,etal.IncreasedlevelsofligandsofToll-likereceptors2and4intype1diabetes[J].Diabetologia,2009,52(8):1665-8.

　　[36]ALKANANIAK,REWERSM,DONGF,etal.DysregulatedToll-likereceptor-inducedinterleukin-1betaandinterleukin-6responsesinsubjectsatriskforthedevelopmentoftype1diabetes[J].Diabetes,2012,61(10):2525-33.

　　[37]SADELAINMW,QINHY,LAUZONJ,etal.PreventionoftypeIdiabetesinNODmicebyadjuvantimmunotherapy[J].Diabetes,1990,39(5):583-9.

　　[38]TIANB,HAOJ,ZHANGY,etal.UpregulatingCD4+CD25+FOXP3+regulatoryTcellsinpancreaticlymphnodesindiabeticNODmicebyadjuvantimmunotherapy[J].Transplantation,2009,87(2):198-206.

　　[39]CARAMALHOI,RODRIGUES-DUARTEL,PEREZA,etal.RegulatoryTcellscontributetodiabetesprotectioninlipopolysaccharide-treatednon-obesediabeticmice[J].ScandJImmunol,2011,74(6):585-95.

　　[40]GULDENE,IHIRAM,OHASHIA,etal.Toll-likereceptor4deficiencyacceleratesthedevelopmentofinsulin-deficientdiabetesinnon-obesediabeticmice[J].PlosOne,2013,8(9):e75385.